Lakefront Biotherapeutics (LKFT) EBT Margin (2014 - 2026)
Lakefront Biotherapeutics (LKFT) reported EBT Margin of -358.92% for the quarter ended Jun 30, 2026, down 598.88 percentage points from 239.96% a year earlier and down 574.25 percentage points from the prior quarter.
Lakefront Biotherapeutics (LKFT) EBT Margin (2014 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Lakefront Biotherapeutics' EBT Margin came in at 30360.99%, up 31265.54 percentage points year-over-year; for the year ended Dec 31, 2025, it was 27050.71%, up 28169.89 percentage points from the prior year.
- EBT Margin has a five-year change of +27049.36 percentage points (years ended Dec 2020 to Dec 2025).
- By year, EBT Margin came in at -1119.18% in the year ended Dec 31, 2024 (-1121.52 pp), 2.35% in the year ended Dec 31, 2023 (+31.71 pp), -29.37% in the year ended Dec 31, 2022 (+21.58 pp) and -50.94% in the year ended Dec 31, 2021 (-52.29 pp).
- Five-year quarterly EBT Margin spans a low of -8167.69% in the quarter ended Dec 31, 2024 and a high of 33453.14% in the quarter ended Dec 31, 2025.
- Year over year, EBT Margin gained in two of the last seven quarters, with an average year-over-year change of +4626.48 percentage points.
- The high point for year-over-year EBT Margin in five years was the quarter ended Dec 31, 2025 (a gain of 41620.84 percentage points); the low point was the quarter ended Dec 31, 2024 (a drop of 8159.83 percentage points).
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at 215.34% (quarter ended Mar 31, 2026), 33453.14% (quarter ended Dec 31, 2025) and -678.61% (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | Lakefront Biotherapeutics | 1.97 Bn | 1.97 Bn | 3.51 Mn | -358.92% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -358.92% |
| Mar 31, 2026 | 215.34% |
| Dec 31, 2025 | 33,453.14% |
| Sep 30, 2025 | -678.61% |
| Jun 30, 2025 | 239.96% |
| Mar 31, 2025 | -208.55% |
| Dec 31, 2024 | -8,167.69% |
| Sep 30, 2024 | -57.26% |
| Mar 31, 2024 | 36.74% |
| Dec 31, 2023 | -7.86% |
| Sep 30, 2023 | -23.23% |
| Jun 30, 2023 | -22.49% |
| Mar 31, 2023 | -19.43% |
| Sep 30, 2022 | -27.58% |
| Jun 30, 2022 | -55.47% |
| Mar 31, 2022 | -8.50% |
| Sep 30, 2021 | -55.27% |
| Jun 30, 2021 | -46.47% |
| Mar 31, 2021 | -11.13% |
| Dec 31, 2020 | -33.68% |
Lakefront Biotherapeutics EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=LKFT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "LKFT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=LKFT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();